Blackstone explores sale of ZO Skin Health, sources say

FILE PHOTO: A logo of Blackstone is pictured in Manhattan, New York City, U.S. July 29, 2025.

FILE PHOTO: A logo of Blackstone is pictured in Manhattan, New York City, U.S. July 29, 2025. (REUTERS/Mike Segar/File Photo)


1 photo
Save Story

Estimated read time: Less than a minute

NEW YORK, Sept 8 — Investment ​firm Blackstone is looking to sell medical-grade skincare company ZO Skin ‌Health, which could be valued at around $2 billion ⁠in any deal, ​according to people ⁠familiar with the matter.

The firm ‌is working with ‌investment bankers at Citigroup and ⁠Raymond James on ⁠the sale, which is at an early stage, the people said, requesting anonymity because the matter is private.

Blackstone and Citi declined to ‌comment. ZO and Raymond James ​did not immediately respond to comment requests.

Dermatologist Dr. Zein Obagi founded the brand in 2007. ZO sells skincare products including cleansers, serums, exfoliators, and toners that are distributed by physicians and skincare ​professionals.

The sale process comes at ‌a time ‌when ⁠many strategic buyers are prioritizing clinically backed, physician-distributed skincare brands like ZO, because of their efficacy and ‌steadier demand versus ​over-the-counter products.

(Reporting by ‌Abigail Summerville in ⁠New ​York; Editing by David French and Edward ​Tobin)

Photos

Most recent Business stories

Related topics

Abigail Summerville

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Notice.
    Newsletter Signup

    KSL Weather Forecast

    KSL Weather Forecast
    Play button